Investigation of transcriptional differences between healthy infected vs morbid infected vs uninfected identified many non-immune pathways unregulated in healthy infected (matching, again, disease tolerance mechanisms rather than antagonistic inflammatory responses)
One major upregulated pathway was iron metabolism - and iron supplementation of diet was sufficient to be completely protective up to 1000x LD100 (>10^10 cfu) of Citrobacter, even with comparable pathogen burden in stool
Dietary iron protected from intestinal epithelial damage, prevented systemic dissemination of Citrobacter, and lowered expression of virulence genes in Citrobacter through an indirect mechanism (not acting on Citrobacter directly) and independently of microbiota
Iron increased glucose levels in the intestine through induction of insulin resistance, resulting in suppression of virulence genes through modulation of pathogen metabolism (glucose alone suppressed Citrobacter virulence genes)
Most excitingly, dietary iron results in evolution of Citrobacter towards non-pathogenic commensal phenotype - stably persisting in the gut, but non-lethal even after removal of iron and, eventually, non-lethal even in untreated mice at >LD100 CFU counts!
In summary: heterogeneity in host response to identical pathogen challenge (the LD50 effect) allowed identification of tolerance mechanisms that are capable of driving a long-term shift in bacterial phenotype towards commensalism. Many questions coming out after reading this…
Dietary iron protected from extra-intestinal dissemination of Citrobacter, but the healthy infected mice at LD50 had comparable Citrobacter loads in all tissues. So what additional tolerance mechanisms are active at LD50 that allow tolerance of systemic Citrobacter?
When do tolerance mechanisms “kick in”? At LD0, do mice show long-term carriage of Citrobacter, or do they clear it completely? Can pre-treatment with LD0 (10^5 cfu) induce tolerance mechanisms that provide greater protection against subsequent LD100 infection?
(This experiment would require right timescale to prevent immune-confounding effects, e.g. memory responses / vaccination or increase in innate responses, e.g. AMP production, that will inhibit initial colonization - does LD0 induce any pathology / persistent inflammation?)
How “cooperative” is this response? Evolved “commensal” citrobacter have no fitness defect (in vitro) - but what is the fitness effect on the host of long-term Citrobacter maintenance? Fig1E shows healthy infected look like LD0 infected, but what about comparison to uninfected?
Overall many interesting lines of thought that arise from these very exciting findings - look forward to seeing the future work! Amazing job by @theayreslab, and now I'm even more excited for her seminar @YaleIBIO next June! #Microbiota#DiseaseTolerance#Evolution
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Here’s a thread on anti-interferon autoantibodies, viral infections, and human immunology. This is less a covid thread, and more an anti-covid thread, if anything…
Summary: anti-IFN auto-Abs may be reflective of chronic inflammation, and may pre-exist in vulnerable groups at high levels. Presence in severe covid cases may therefore reflect basal immune variation which impacts covid, rather than a special covid-specific phenomenon.
This is prompted based on the new Science paper on autoantibodies against Type I IFNs in severe covid patients (science.sciencemag.org/content/early/…). Basically, ~10% of severe covid patients had high titer anti-IFNa antibodies that were functionally neutralizing.
I'm grateful that others have put together resources like bit.ly/ANTIRACISMRESO…, which has helped me learn to be better. So You Want To Talk About Race by @IjeomaOluo and How To Be An Antiracist by @DrIbram have been amazing, and I'm looking forward to reading deeper.
I haven't seen a similar central resource for donations, but various recommendations led me to eji.org (Equal Justice initiative, focused on criminal justice reform and education), voterparticipation.org (get people registered to vote)...
The original paper, which was mainly based on the temperature-dependent fluorescence of a mitochondria-targeting probe, was accompanied by a “Primer” (journals.plos.org/plosbiology/ar…) highlighting potential flaws and implications, a special sort-of-peer-review step by PLOS Biology.
This new awesome resource @naturemethods - nature.com/articles/s4159… - offers some intriguing orthogonal validation. This is a proteome-wide study of protein thermal stability across 13 organisms, conducted using a mass-spec-based approach.
Super neat story on how cellular quality control impacts the mutational landscape of proteins - beneficial mutations in DHFR during deep mutational scanning are totally altered dependent on cellular QC #Biophysics#Evolutionbiorxiv.org/content/10.110… Way to go! @KortemmeLab
In an initial DMS experiment on DHFR, there were a large number (25% of all sequences!) of advantageous mutations spread across the whole protein. Reintroduction of QC protein Lon reduced the number of advantageous mutants and lowered average benefit of those mutations
Changes in selection coefficient (the “advantageous-ness”) were most striking at hydrophobic/aromatic residues and buried residues - and these correlate with Tm changes of variants. So Lon seems to be imposing higher standards on DHFR, particularly for destabilizing core mutants
A couple interesting bits of preliminary data on Langerhans cells and the huLangerin mouse used to study them. Effects of developmental absence of LCs on keratinocytes and T cells, and huLangerin-YFP labels some neurons (check your Cre mice!) #Genetics#Immunology
First - effect of loss of LCs in the huLangerin-DTA mice - biorxiv.org/content/10.110…. Bulk RNA-seq showed changes in keratinocytes and dendritic epidermal T cells, including cell-type specific changes (e.g. loss of IL17 pathway in DETCs).
Unfortunately, underlying data (either gene expression tables or raw RNA-seq data) don’t currently seem available, but hopefully the authors get that up shortly. Will be interesting to look at and prompt some hypotheses about how LCs control homeostasis and development.
CYTOF analysis of human neutrophils - 7 populations with differing phagocytosis, ROS, and FACS-compatible surface marker phenotypes. Changes in distribution between healthy + melanoma patients. #Immunology#Cancer#Neutrophilsbiorxiv.org/content/10.110…
Circulating neutrophil precursors, aged neutrophils, and a few populations of mature and immature neutrophils. Melanoma stage correlates with loss of dominant N2 (mature, ROS++, lowly phagocytic), and increase of N5 (immature, non-proliferative, ROS+, lowly phagocytic).
Interesting to note the phagocytosis-SSC staining in Fig4A - big changes in SSC for some populations with zymosan, others not so much - degranulation, different phagosomes…? Similarly, bimodal peaks for ROS production in same populations…